版本:
中国

BRIEF-Aveo announces submission of response to Tivozanib marketing authorization application day 180 list of outstanding issues

April 13 Aveo Pharmaceuticals Inc:

* Aveo announces submission of response to tivozanib marketing authorization application day 180 list of outstanding issues

* Aveo Pharma - EUSA remains tentatively scheduled to provide oral explanation to EMA's committee for medicinal products for human use at May 2017 meeting Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐